PAUL GETTINGER: Open Payments
NPI 1891791810 · BREMEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 24 payments from 12 companies in 2025. Trend: 2023 $646 · 2024 $813 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| ABBVIE INC. | 3 | $59 |
| PFIZER INC. | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $18 |
Products named: JARDIANCE, NURTEC ODT, Auvelity, AIRSUPRA, CAPLYTA, Cologuard Collection Kit, VOWST, Qelbree.
Industry payments across IN — which companies pay providers there.
